What adverse effects can occur in newborns exposed to zuclopenthixol dihydrochloride during the third trimester of pregnancy?

Newborns exposed to zuclopenthixol dihydrochloride during the third trimester may develop extrapyramidal and/or withdrawal symptoms of varying severity and duration, including agitation, increased or reduced muscle tone, tremor, sleepiness, respiratory distress or feeding difficulties, and should be monitored carefully.